Annual EBITDA
-$26.46 M
+$8.62 M+24.58%
30 September 2023
Summary:
ESSA Pharma annual earnings before interest, taxes, depreciation & amortization is currently -$26.46 million, with the most recent change of +$8.62 million (+24.58%) on 30 September 2023. During the last 3 years, it has risen by +$10.25 million (+27.93%). EPIX annual EBITDA is now -1444.38% below its all-time high of -$1.71 million, reached on 30 September 2014.EPIX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$7.21 M
+$1.76 M+19.58%
30 June 2024
Summary:
ESSA Pharma quarterly earnings before interest, taxes, depreciation & amortization is currently -$7.21 million, with the most recent change of +$1.76 million (+19.58%) on 30 June 2024. Over the past year, it has dropped by -$1.76 million (-32.24%). EPIX quarterly EBITDA is now -281.83% below its all-time high of $3.97 million, reached on 30 June 2017.EPIX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$27.57 M
+$55.80 K+0.20%
30 June 2024
Summary:
ESSA Pharma TTM earnings before interest, taxes, depreciation & amortization is currently -$27.57 million, with the most recent change of +$55.80 thousand (+0.20%) on 30 June 2024. Over the past year, it has dropped by -$1.12 million (-4.22%). EPIX TTM EBITDA is now -12121.99% below its all-time high of -$225.60 thousand, reached on 31 December 2013.EPIX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EPIX EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -32.2% | -4.2% |
| 3 y3 years | +27.9% | +15.4% | +24.9% |
| 5 y5 years | -118.3% | -125.6% | -127.8% |
EPIX EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +27.9% | -32.2% | +33.0% | -7.3% | +29.7% |
| 5 y | 5 years | -118.3% | +27.9% | -125.6% | +44.3% | -127.8% | +29.7% |
| alltime | all time | -1444.4% | +27.9% | -281.8% | +44.3% | <-9999.0% | +29.7% |
ESSA Pharma EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$7.21 M(-19.6%) | -$27.57 M(-0.2%) |
| Mar 2024 | - | -$8.97 M(+50.9%) | -$27.63 M(+7.6%) |
| Dec 2023 | - | -$5.94 M(+9.0%) | -$25.69 M(-2.9%) |
| Sept 2023 | -$26.46 M(-24.6%) | -$5.45 M(-25.0%) | -$26.46 M(-3.3%) |
| June 2023 | - | -$7.27 M(+3.4%) | -$27.36 M(-5.1%) |
| Mar 2023 | - | -$7.03 M(+4.7%) | -$28.83 M(-11.5%) |
| Dec 2022 | - | -$6.71 M(+5.5%) | -$32.56 M(-6.7%) |
| Sept 2022 | -$35.08 M(-4.4%) | -$6.36 M(-27.2%) | -$34.91 M(-5.9%) |
| June 2022 | - | -$8.73 M(-18.8%) | -$37.08 M(+0.1%) |
| Mar 2022 | - | -$10.76 M(+18.7%) | -$37.05 M(-5.6%) |
| Dec 2021 | - | -$9.06 M(+6.3%) | -$39.24 M(+6.9%) |
| Sept 2021 | -$36.71 M(+59.6%) | -$8.53 M(-2.1%) | -$36.71 M(+12.6%) |
| June 2021 | - | -$8.71 M(-32.7%) | -$32.60 M(+14.0%) |
| Mar 2021 | - | -$12.94 M(+98.0%) | -$28.60 M(+14.9%) |
| Dec 2020 | - | -$6.54 M(+47.7%) | -$24.89 M(+8.2%) |
| Sept 2020 | -$23.01 M(+89.9%) | -$4.42 M(-5.9%) | -$23.01 M(+5.6%) |
| June 2020 | - | -$4.70 M(-49.1%) | -$21.78 M(+7.7%) |
| Mar 2020 | - | -$9.23 M(+98.7%) | -$20.22 M(+42.1%) |
| Dec 2019 | - | -$4.65 M(+45.4%) | -$14.23 M(+17.6%) |
| Sept 2019 | -$12.12 M | -$3.20 M(+1.7%) | -$12.10 M(+10.4%) |
| June 2019 | - | -$3.14 M(-3.2%) | -$10.97 M(+4.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$3.25 M(+28.9%) | -$10.45 M(-7.9%) |
| Dec 2018 | - | -$2.52 M(+22.3%) | -$11.34 M(+6.4%) |
| Sept 2018 | -$10.66 M(+200.0%) | -$2.06 M(-21.5%) | -$10.66 M(+3.6%) |
| June 2018 | - | -$2.62 M(-36.5%) | -$10.28 M(+178.4%) |
| Mar 2018 | - | -$4.14 M(+125.4%) | -$3.69 M(-46.8%) |
| Dec 2017 | - | -$1.84 M(+8.7%) | -$6.94 M(+95.3%) |
| Sept 2017 | -$3.55 M(-70.4%) | -$1.69 M(-142.6%) | -$3.55 M(-40.7%) |
| June 2017 | - | $3.97 M(-153.7%) | -$5.99 M(-56.4%) |
| Mar 2017 | - | -$7.38 M(-575.9%) | -$13.75 M(+111.6%) |
| Dec 2016 | - | $1.55 M(-137.6%) | -$6.50 M(-45.8%) |
| Sept 2016 | -$11.98 M(+25.6%) | -$4.13 M(+8.8%) | -$11.98 M(+63.8%) |
| June 2016 | - | -$3.80 M(+2928.8%) | -$7.32 M(-16.7%) |
| Mar 2016 | - | -$125.30 K(-96.8%) | -$8.79 M(-27.9%) |
| Dec 2015 | - | -$3.94 M(-832.4%) | -$12.18 M(+27.7%) |
| Sept 2015 | -$9.54 M(+457.0%) | $537.30 K(-110.2%) | -$9.54 M(-9.2%) |
| June 2015 | - | -$5.26 M(+49.6%) | -$10.51 M(+70.3%) |
| Mar 2015 | - | -$3.52 M(+171.9%) | -$6.17 M(+122.2%) |
| Dec 2014 | - | -$1.29 M(+199.2%) | -$2.78 M(+62.5%) |
| Sept 2014 | -$1.71 M | -$432.60 K(-53.3%) | -$1.71 M(+33.9%) |
| June 2014 | - | -$926.40 K(+645.3%) | -$1.28 M(+264.8%) |
| Mar 2014 | - | -$124.30 K(-44.9%) | -$349.90 K(+55.1%) |
| Dec 2013 | - | -$225.60 K | -$225.60 K |
FAQ
- What is ESSA Pharma annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for ESSA Pharma?
- What is ESSA Pharma quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for ESSA Pharma?
- What is ESSA Pharma quarterly EBITDA year-on-year change?
- What is ESSA Pharma TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for ESSA Pharma?
- What is ESSA Pharma TTM EBITDA year-on-year change?
What is ESSA Pharma annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of EPIX is -$26.46 M
What is the all time high annual EBITDA for ESSA Pharma?
ESSA Pharma all-time high annual earnings before interest, taxes, depreciation & amortization is -$1.71 M
What is ESSA Pharma quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of EPIX is -$7.21 M
What is the all time high quarterly EBITDA for ESSA Pharma?
ESSA Pharma all-time high quarterly earnings before interest, taxes, depreciation & amortization is $3.97 M
What is ESSA Pharma quarterly EBITDA year-on-year change?
Over the past year, EPIX quarterly earnings before interest, taxes, depreciation & amortization has changed by -$1.76 M (-32.24%)
What is ESSA Pharma TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of EPIX is -$27.57 M
What is the all time high TTM EBITDA for ESSA Pharma?
ESSA Pharma all-time high TTM earnings before interest, taxes, depreciation & amortization is -$225.60 K
What is ESSA Pharma TTM EBITDA year-on-year change?
Over the past year, EPIX TTM earnings before interest, taxes, depreciation & amortization has changed by -$1.12 M (-4.22%)